Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00941317 · ClinicalTrials.gov registry record · Phase 1
Single-blind Evaluation of Device to Nail Micro-drilling in Onychomycosis
A Phase 1 study of Onychomycosis, sponsored by Galderma R&D.
- Completed
- Registry status
- Phase 1
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT00941317: Completed Phase 1 study of Onychomycosis, sponsored by Galderma R&D.
NCT00941317 is a Phase 1 study of Onychomycosis that has completed, run by Galderma R&D. The registered enrollment target is 25 participants, below the 92-participant average among 11 other Onychomycosis trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00941317, a Phase 1 study of Onychomycosis, has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
Based on manufacturer testing, no major difference in drilling condition is expected in this study compared to the drilling conditions previously established. However clinical testing is needed to establish optimal drilling conditions to be used for further development in both unaffected and affected parts of the nail. The aim of this study is to determine the optimal drilling condition that could be used in future studies of this device in combination with topical treatment for onychomycosis.
Conditions Studied
Interventions
- DEVICE Pathformer (micro-drilling device)
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2009-07 |
| Est. Completion | 2009-09 |
| Phase | Phase 1 |
What the finished NCT00941317 record still lists
NCT00941317 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 92-participant average among 11 other Onychomycosis trials with a reported enrollment target (73% lower).
The record links to 1 condition, with Onychomycosis appearing as the primary indexed condition, and to 1 intervention - of which Pathformer (micro-drilling device) is the first listed.
NCT00941317 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00941317 about?
NCT00941317 is a clinical study titled "Single-blind Evaluation of Device to Nail Micro-drilling in Onychomycosis". Based on manufacturer testing, no major difference in drilling condition is expected in this study compared to the drilling conditions previously established. However clinical testing is needed to establish optimal drilling conditions to be used for further development in both unaffected and affecte...
What is the current status of trial NCT00941317?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 25 participants. The study started on 2009-07. Estimated completion is 2009-09.
What conditions does trial NCT00941317 study?
This clinical trial studies the following conditions: Onychomycosis.
What interventions are being tested in trial NCT00941317?
The interventions under investigation include: Pathformer (micro-drilling device) (DEVICE).
Who is sponsoring clinical trial NCT00941317?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00941317 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Onychomycosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00941317's enrollment target sits among peer trials
25 9th of 11 higher than 2 of 11 other Onychomycosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Onychomycosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pharmacokinetics and Safety Study of ME1111 in Moderate to Severe Onychomycosis Patients
COMPLETED · Phase 1
-
A Vehicle-controlled Study of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO)
ACTIVE NOT RECRUITING · Phase 3
-
Treatment of Onychomycosis Using a 0.65 Millisecond Pulsed Nd:YAG 1064 nm Laser
COMPLETED · NA
-
Absorption and Systemic Study of AN2690 in Patients With Moderate to Severe Onychomycosis (ADME II)
COMPLETED · Phase 2
-
Spread of Dermatophytes Among Families
COMPLETED
-
Study of the Use of Low Level Laser Light Therapy to Treat Toenail Fungus
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia